Comparison of Sepsis Prediction Algorithms
Launched by EMORY UNIVERSITY · Jul 5, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to improve the early detection of sepsis, a serious condition that can occur when the body has a severe response to infection. Each year, over 1.5 million people in the U.S. are diagnosed with sepsis, and it can sometimes lead to death if not treated quickly. The researchers will compare three different computer programs, known as sepsis prediction algorithms, that analyze patient information from electronic health records (EHR) to see which one is best at predicting sepsis early on. While these programs will run in the background of the healthcare system, they won't change how any patient's care is delivered, and patients or staff won't see the predictions.
If you are an adult who goes to the emergency department (ED) at Emory healthcare, you might be eligible to be part of this study. There are no specific exclusions, so most adults admitted through the ED can participate. The trial is not yet recruiting participants, but when it begins, it will focus on gathering data to help improve sepsis detection, ultimately aiming to save lives by ensuring quicker treatment for those who need it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients admitted through the ED
- Exclusion Criteria:
- • None
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Johns Creek, Georgia, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Decatur, Georgia, United States
Lithonia, Georgia, United States
Patients applied
Trial Officials
Sivasubramanium Bhavani, MD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported